CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Charles River Laboratories International, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and growth rate from Q1 2019 to Q4 2023.
  • Charles River Laboratories International, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending December 30, 2023 was $63.4M, a 0.39% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $63.4M -$246K -0.39% Dec 30, 2023 10-K 2024-02-14
Q4 2022 $63.7M +$22.7M +55.5% Dec 31, 2022 10-K 2023-02-22
Q4 2021 $41M +$13.2M +47.3% Dec 25, 2021 10-K 2022-02-16
Q3 2021 $39M +$12.6M +47.6% Sep 25, 2021 10-Q 2021-11-03
Q2 2021 $36.7M +$11.1M +43.6% Jun 26, 2021 10-Q 2021-08-04
Q1 2021 $28.2M +$940K +3.44% Mar 27, 2021 10-Q 2021-05-04
Q4 2020 $27.8M +$2.78M +11.1% Dec 26, 2020 10-K 2021-02-17
Q3 2020 $26.4M +$913K +3.58% Sep 26, 2020 10-Q 2020-11-09
Q2 2020 $25.5M +$1.5M +6.22% Jun 27, 2020 10-Q 2020-08-05
Q1 2020 $27.3M +$4.39M +19.2% Mar 28, 2020 10-Q 2020-05-07
Q4 2019 $25M Dec 28, 2019 10-K 2020-02-11
Q3 2019 $25.5M Sep 28, 2019 10-Q 2019-11-06
Q2 2019 $24M Jun 29, 2019 10-Q 2019-07-31
Q1 2019 $22.9M Mar 30, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.